Sigma Healthcare (ASX:SIG) Cash Flow for Dividends: A$-158 Mil (TTM As of Dec. 2025)


ASX:SIG Sigma Healthcare Ltd ASX:SIG
59 GF Score
Price A$2.77
GF Value A$0.37
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Sigma Healthcare Cash Flow for Dividends?

Sigma Healthcare ASX:SIG -1.07% 59 Cash Flow for Dividends is A$-158 Mil as of Dec. 2025. GuruFocus rates ASX:SIG with a GF Score™ of 59/100 and a GF Value™ of A$0.37 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Sigma Healthcare's cash flow for dividends for the six months ended in Dec. 2025 was A$-150 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was A$-158 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Sigma Healthcare's quarterly payment of dividends increased from Jul. 2024 (A$-8 Mil) to Jan. 2025 (A$-9 Mil) and increased from Jan. 2025 (A$-9 Mil) to Dec. 2025 (A$-150 Mil).

Sigma Healthcare's annual payment of dividends declined from Jan. 2023 (A$-16 Mil) to Jan. 2024 (A$-11 Mil) but then increased from Jan. 2024 (A$-11 Mil) to Jan. 2025 (A$-17 Mil).

Sigma Healthcare Cash Flow for Dividends Related Terms

Sigma Healthcare Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Sigma Healthcare's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sigma Healthcare Cash Flow for Dividends Chart

Sigma Healthcare Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.59 -19.93 -15.94 -10.79 -17.13

Sigma Healthcare Semi-Annual Data
Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.79 -5.00 -8.50 -8.63 -149.56
ASX:SIG
59GF Score
Sigma Healthcare Ltd ASX:SIG
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sigma Healthcare Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-158 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of A$-158 Mil mean?
Sigma Healthcare (ASX:SIG) has a Cash Flow for Dividends of A$-158 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Sigma Healthcare and its competitors.
Is Sigma Healthcare's Cash Flow for Dividends too high?
Sigma Healthcare's current Cash Flow for Dividends is A$-158 Mil. Overall, Sigma Healthcare has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's Cash Flow for Dividends compare to MCK and COR?
Sigma Healthcare's Cash Flow for Dividends of A$-158 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Distribution company?
A good Cash Flow for Dividends depends on the Medical Distribution industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Sigma Healthcare and its competitors. Sigma Healthcare's current Cash Flow for Dividends is A$-158 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sigma Healthcare (ASX:SIG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.37, compared to a current price of A$2.77 — trading 648.6% above its estimated fair value. The current Cash Flow for Dividends is A$-158 Mil. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Sigma Healthcare (ASX:SIG), the current Cash Flow for Dividends is A$-158 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?

Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued. The current stock price of A$2.77 is trading 648.6% above its estimated GF Value™ of A$0.37. GuruFocus considers Sigma Healthcare to be Significantly Overvalued.

Key valuation signals for ASX:SIG:

  • Cash Flow for Dividends: A$-158 Mil
  • GF Value™: A$0.37 vs. price of A$2.77 (648.6% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sigma Healthcare Business Description

Address 6 Albert Street, Preston, VIC, AUS, 3072
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score

Get the complete analysis for ASX:SIG

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.77
Price
A$0.37
GF Value